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ABSTRACT
Purpose: Two quality controlled inter-laboratory exercises were organized within the EU project
‘Realizing the European Network of Biodosimetry (RENEB)’ to further optimize the dicentric chromosome
assay (DCA) and to identify needs for training and harmonization activities within the RENEB network.
Materials and methods: The general study design included blood shipment, sample processing, ana-
lysis of chromosome aberrations and radiation dose assessment. After manual scoring of dicentric chro-
mosomes in different cell numbers dose estimations and corresponding 95% confidence intervals were
submitted by the participants.
Results: The shipment of blood samples to the partners in the European Community (EU) were per-
formed successfully. Outside the EU unacceptable delays occurred. The results of the dose estimation
demonstrate a very successful classification of the blood samples in medically relevant groups. In com-
parison to the 1st exercise the 2nd intercomparison showed an improvement in the accuracy of dose
estimations especially for the high dose point.
Conclusions: In case of a large-scale radiological incident, the pooling of ressources by networks can
enhance the rapid classification of individuals in medically relevant treatment groups based on the
DCA. The performance of the RENEB network as a whole has clearly benefited from harmonization
processes and specific training activities for the network partners.
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Introduction
The dicentric chromosome assay (DCA), is considered the
‘gold standard’ for radiation biodosimetry (Blakely et al.
2009), and as an important tool for radiation dose assess-
ment in small-scale and large-scale radiation accidents. It is
necessary to establish an operational network in biodosime-
try to handle large numbers of potentially overexposed vic-
tims for mutual assistance in case of an emergency. A
requirement for acting as an operational network is to
achieve comparable results and to apply high-performance
standards by all network partners in the techniques used.
Quality controlled inter-laboratory exercises were carried out
within the RENEB (Realizing the European Network of
Biodosimetry) project to guarantee and continuously opti-
mise these basic principles for the DCA. Activities to further
enhance performance quality have been identified and
implemented in the operational basis of the RENEB network
(Kulka et al. 2012, 2015). For this purpose two practical
exercises were organized. The first exercise (1st), included
18 participating laboratories of the RENEB consortium and
was organised in two parts (A and B). Initially, part A con-
sisted of the scoring of electronically provided images with
the aim of harmonizing scoring criteria between the RENEB
partners. The results and further details of this work are
described in the paper by Romm et al. (2016), included in
this special issue. In part B a realistic accident situation was
simulated by sending irradiated blood samples to the par-
ticipating RENEB partners. In addition to the dose estima-
tions, culture conditions and dose effect curves used by
each partner for dose calculations were reported. Based on
the outcome of this 1st intercomparison, recommendations
to reduce inter-laboratory variability and the opportunity for
training events in RENEB partner laboratories were offered
before the second exercise (2nd) was initiated. This 2nd
intercomparison was intended to be on a global level and
the number of participants was significantly increased. In
addition to RENEB partners, RENEB candidate laboratories,
those intending to join the network in the future, and net-
works and institutions outside the European community
were included. The aim was to survey the performance of
the RENEB network and assess the level of improvement
since the first exercise, and in addition to compare the
results on an international level.
In total, 42 laboratories from 31 countries participated in
this global second exercise. The general study design
included blood shipment, sample processing, analysis of
chromosome aberrations and dose assessment. Blood sam-
ples from healthy donors were irradiated in vitro with
gamma rays in one laboratory and coded aliquots were sent
to the participants. The task was to culture blood lympho-
cytes and prepare cytogenetic slides according to each labo-
ratories’ standard protocol. Radiation doses were assessed
based on the observed yield of aberrations with reference to
an appropriate calibration curve in each laboratory. The aim
was to determine whether the estimated radiation doses of
the participating laboratories were in good agreement with
the actual given dose, or if there was a need for further train-
ing and harmonization within RENEB.
Materials and methods
Irradiation and shipment
1st exercise, Part B
Eighteen laboratories from 14 European countries involved in
the RENEB consortium joined the first quality controlled exer-
cise for the dicentric chromosome assay (DCA) in March
2013. Blood samples (10ml heparinized tubes) from four
healthy donors, three female (22, 38 and 52 years) and one
male person (45 years) were irradiated with 137-Cs gamma
rays (dose rate 0.495Gy/min) in a HWM D 2000 unit
(W€alischmiller Engineering GmbH, Markdorf, Germany; for-
merly Hans W€alischmiller GmbH). Peripheral blood samples
were obtained, with informed consent, from healthy adult
donors, in accordance with ethics approval no. 12084. All
blood tubes for each dose point were irradiated simultan-
eously. In Table 1, the radiation details and donor informa-
tion are given. For one blood sample (coded as RENEB 2), a
partial body exposure (PB) was simulated, irradiated blood
and unirradiated blood of one donor was mixed in a 1:1 ratio
(50% irradiated blood volume). For the simulation of whole-
blood exposure (WB) blood samples (coded as RENEB 1,3,4)
were homogenously irradiated.
After a repair time of 2 h at 37 C the blood was aliquoted
to 2 and 5ml tubes or retained in the 10ml tubes depending
on the total amount of blood needed by the participating
laboratories. Blood samples were then coded and sent to the
participants of the exercise. Shipment was performed by
express service as UN 3373 Biological Substance Category B
described in detail in the manual of the International Atomic
Energy Agency (IAEA 2011). Each package of blood samples
Table 1. Details of irradiation of blood samples for 1st and 2nd exercise and donor information are given.
Sample Dose (Gy)
Dose rate
(Gy/min)
Irradiation
time (min) Scenario Donor/gender
Donor/age
(years)
Exercise
1st 0.495
RENEB 1 (Re1) 3.27 6.6 WB f 22
RENEB 2 (Re2) 4.75 9.6 PB f 38
RENEB 3 (Re3) 0.00 0 WB m 45
RENEB 4 (Re4) 0.94 1.9 WB f 52
2nd 0.478
RENEB 5 (Re5) 0.85 1.8 WB f 31
RENEB 6 (Re6) 2.7 5.6 WB m 22
WB: whole body simulation; PB: partial body simulation.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY 21
included a temperature logger and a dosimeter to monitor
the temperature and any dose received by the samples dur-
ing transport.
2nd exercise
The 2nd exercise in October 2014 also simulated a realistic
accident situation and was carried out in a similar manner to
the 1st exercise procedure. Two coded blood samples (RENEB
5 and 6) from two healthy donors were homogenously irradi-
ated and distributed to the participating laboratories. The
procedure and equipment (HWM D 2000) were the same as
for the 1st exercise part B (Table 1).
Nineteen RENEB partners from 14 European countries and
four laboratories from three European countries, not included
in the RENEB project at this time (known as RENEB candi-
dates) were involved in this 2nd intercomparison. In addition,
non EU partners, 19 labs from 16 countries (Asian Network,
Canada Network and United States partners, Latin America
Network, South African Partners, members of BioDoseNet/
WHO, members of IAEA Network) participated in this second
exercise.
In total 42 laboratories from 31 countries from all over the
world participated in this global exercise using the DCA for
dose assessment. Shipments were performed in the way as
for the 1st exercise. The shipment to three laboratories out-
side of the European Community had to be repeated, using
a specialized shipment service for diagnostic materials. For
these shipments a temperature controlled transportes box
(15–25 C) was used.
Cell cultures and dicentric chromosomes analysis (DCA)
(1st and 2nd exercise)
Each laboratory was requested to set up at least two lympho-
cyte cultures per sample following their own standard proto-
cols, and considering the IAEA recommendations (IAEA 2011)
and International Organization for Standardization (ISO)
standards (ISO 19238: 2014; ISO 21243: 2008). Cell cycle con-
trolled scoring was applied according to the standard proto-
cols of each particular Laboratory. Information about culture
variables and calibration curve details have been requested
in the scoring sheet as well.
For the non EU networks the sample processing, slide
preparation and staining were conducted for each regional
or supra-regional network at one particular contact labora-
tory in Canada, South Africa, Uruguay or Japan. From these
central laboratories, slides for each sample were then distrib-
uted to the participating network laboratories. The analyses
were performed according to the RENEB standard scoring
sheet which was provided to the participants (50 cells/slide
and two slides/dose-point). The results (dose estimates,
dicentric frequency and scoring sheets) were returned to the
contact laboratory for each regional or supra-regional
network for compilation.
The manual scoring of dicentric chromosomes (Dic) was
adapted to handle a large number of samples. Therefore
dose estimations were performed based on the yield of
aberrations analyzed in 20, 30 and 50 cells/slide. In total two
slides (a, b) with up to 50 cells each were analyzed per dose
point by each laboratory. To facilitate the comparison of the
scoring results, a harmonized scoring sheet was circulated to
all participants.
Dose assessment
For dose estimation the laboratories used their own calibra-
tion curves based on dicentric chromosomes (Dic) or dicen-
tric chromosomes plus centric rings (Dicþ cR) according to
the particular established protocol. All calibration curves
were generated by fitting the yield of aberrations to linear-
quadratic dose dependencies. The dose estimations were
performed with the free software CABAS V2.0 (Deperas et al.
2007) or different versions of Dose-Estimate (Ainsbury and
Lloyd 2010), except for three laboratories who used their
own software. The partners estimated a dose in gray (Gy)
and the corresponding 95% confidence intervals according to
the number of dicentrics or dicentrics plus centric rings
scored. To identify partial body exposure, the distribution of
dicentrics was analysed for deviation from Poisson with the
Papworth u-test. In case the u-test was significant, a partial
body dose was estimated together with the irradiated vol-
ume of the body using the Dolphin method (IAEA 2011),
assuming a mean lethal dose of 3.5 Gy for gamma rays
(Matsubara et al. 1974).
Statistics
The coefficient of variation (CV), trueness and z-values were
calculated as described by Di Giorgio et al. (2011), according
to ISO 5725 (ISO 5725, 1998) and ISO 13528 (ISO 13528,
2005). The CV was used to compare the reproducibility of
the dose assessments and was defined as the ratio SR/x in
percent, where SR is the robust standard deviation and x is
the robust average. The trueness was calculated as (x- true
dose)/x and represents the agreement between the robust
estimated average dose of the participating laboratories and
the applied true dose. In addition, for each estimated dose a
z-score of the dose was calculated. The z-score allows classifi-
cation of the participants’ results as satisfactory (j z j< 2),
questionable (2< j z j<3) and unsatisfactory (j z j> 3) (IAEA
2011).
Results
Shipment
Almost all blood samples in both exercises were delivered
within 24 h inside the European Community without any dif-
ficulties. Two RENEB labs received the samples directly
because they were next to the irradiation facility. For one
RENEB partner the delivery was slightly delayed and arrived
in the laboratory after 28 h.
The dosimeters used during all shipments did not record
any dose above 1 mSv. The thermologgers showed a wide
range between 11 and 30 C for the 1st exercise and
between 11 and 29 C for the 2nd exercise.
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For the shipments outside the European Community
(Canada, South Africa, Japan, Uruguay, Serbia) carried out in
October 2014 only the packages to Japan and South Africa
reached their destination, but with a considerable delay: 63 h
for Japan and 75 h for South Africa. However, in both cases
cell culture and chromosome analysis was still possible. The
packages to Canada and Uruguay never left Europe, even
though the shipment was done in accordance with the regu-
lations and packing Instructions 650 for Biological
Substances, Category B, because of restrictive customs issues.
The package to Serbia, although in Europe but not within
the European Union (EU), exceeded a delivery period of 96 h.
It was decided to stop the shipments to Serbia, Canada and
Uruguay because of these excessive delays and repeat the
shipment for the three non-EU partners (Canada, Uruguay
and Serbia) using a specialized shipment service for diagnos-
tic materials. The second shipment, unfortunately, had to be
postponed due to an ad hoc strike by airline pilots, but
finally the blood samples were delivered successfully in tem-
perature controlled transport boxes (15–25 C). The
duration of shipment to Canada was 47 h, Uruguay 44 h and
Serbia 46 h.
Variables of lymphocytes culturing
According to the recommendations given after the first inter-
comparison to the labs with unsatisfactory results, seven
RENEB partners adapted the conditions of lymphocyte cul-
tures changing the final concentration of BromodeoxyUridine
(5-Bromo-2-DeoxyUridine, BrdU) and/or the concentration
and incubation time of Colcemid to increase and improve
the quality and quantity of metaphases and to guarantee cell
cycle controlled scoring. Two partners also received training
in a RENEB partner laboratory. According to the question-
naire received from the participants almost all laboratories
(RENEB partners and RENEB candidates) performed whole
blood culturing with Roswell Park Memorial Institute medium
(RPMI 1640) as culture media supplemented with fetal calf
serum (FCS) (10–25%). For the participating networks outside
of Europe the coordination laboratories in Latin America and
Asia preferred to isolate lymphocytes for culture performance
while the others used whole blood cultures. Here also RPMI
1640 is the medium of choice. Two laboratories (RENEB part-
ners, non-EU laboratories) used Minimum Essential Media
(MEM) known to achieve a lower growth rate of blood lym-
phocytes. For the labs (RENEB, RENEB candidates and non-EU
countries) using BrdU for cell cycle control the range of con-
centration in the final culture mixture varied from 3–12 lg/
ml but did not exceed the IAEA recommendations. For
mitotic arrest Colcemid was used by 14 RENEB laboratories 2
and 4 h before terminating the cultures with a final concen-
tration of 0.05–10 lg/ml. According to the IAEA manual con-
centration >0.1 lg/ml can cause problems of cell toxicity.
Three labs added Colcemid after 24 h with a lower
Colcemid concentration of 0.04 lg/ml – up to a maximum of
0.1 lg/ml.
For two RENEB candidates the cell-cycle controlled scoring
was not a standard scoring procedure according to the ques-
tionnaires. For the non-Europe participants the contact
laboratories responsible for processing the samples and pre-
paring slides had standardized cell cycle-controlled protocols.
Dose effect curves
Most participating laboratories used their own calibration
curves for dose estimations from the manually observed
aberration frequencies. For the RENEB partners the most
commonly used source of radiation used for establishing the
dose effect curves was Co-60 or to a lesser extent Cs-137.
The dose rate varied between 0.24–1Gy/min and most labs
irradiated at 37 ± 0.5 C. The quality of the curves differed
regarding the cell number analysed (between 1000 and
100,000 cells per curve), and in some curves there was no
background frequency. Two laboratories did not have their
own curves available and used dose effect curves from the
literature or from other laboratories. This approach showed
suboptimal results in the first exercise. As a consequence,
one of these two laboratories established a new calibration
curve by increasing the number of analyzed cells and the
other lab adapted their curve fitting procedure.
The majority of the RENEB candidates and non-EU partici-
pants had established their own dose effect curves for Co-60
gamma rays and some for Cs-137. The dose rates used for
the curves were 0.09–1.16Gy/min. Most of the participants
irradiated the blood samples for the dose effect curve at
room temperature. The number of analyzed cells used for
curve fitting was in the range of 1500–28,000 cells.
The shape of the dose effect curves for all participants is
shown in Figure 1. A total of 28 labs used the frequency of
dicentric chromosomes to establish their curve and for dose
estimations. The other 14 laboratories included dicentric
chromosomes plus centric rings.
Dose estimation
The dose estimations were performed by all participating lab-
oratories either with the free software CABAS V2.0 (Deperas
et al. 2007) or different versions of Dose-Estimate (Ainsbury
and Lloyd 2010), three participants used their own software
tools. The 95% confidence interval was given using different
methods, combined Poisson error or exact Poisson error
(detailed description or details are given in IAEA 2011).
In both exercises, two laboratories from the RENEB consor-
tium, but different for the 1st and the 2nd exercise, could
not analyze enough cells for dose estimations because the
culturing of the blood samples was unsatisfactory or failed
completely. There was no obvious reason for the failures and
no relation to culture media or additives was apparent.
In order to contribute to the intercomparison with a dose-
estimation, these labs received cell suspension or slides from
another partner for scoring. The ‘Quick score’ method, count-
ing of clearly visible dicentrics in apparently complete cells,
described in detail by Flegal et al. (2010), was applied by one
lab, all other labs scored complete cells with verifiable 46
centromeres (as detailed in IAEA 2011).
In the 1st exercise only the RENEB partners were included.
Each laboratory was able to identify correctly the sham con-
trol, the low and the high dose sample as well as the partial
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body sample. The accuracy of the dose estimations was very
good for the control and the low dose point (0.94 Gy). When
considering a ± 0.5 Gy uncertainty interval, based on the
number of cells scored, for the true dose of 0.94 Gy, 81% of
the reported dose estimations were correctly classified. The
dose range according to the reported dose assessments was
between 0.26 and 1.85 Gy and the z-test from two laborato-
ries gave questionable values.
The results for the high dose point (3.27 Gy) were less
clear in the 1st exercise. While the z-values were satisfactory
for the majority of the estimated doses, only 40% of the
dose estimations were correctly classified and within
the ±20% uncertainty interval, used for the high dose point.
The dose range according to the reported dose assessments
was 2.2–5.6 Gy. Based on these findings, the need to opti-
mize the results by identifying weak spots in the laboratories
performance and to conduct training events was evident.
In the 2nd exercise, the lower true physical dose for irradi-
ation of one blood sample RENEB 5 (Re5) was 0.85Gy. In
Figure 2 the diagram on the top shows a very good agree-
ment of the number of dicentrics in 50 cells/slide for all the
participating laboratories with the theoretically expected
range. This range refers to the mean number of dicentrics of
all laboratories (5.13 dics/50 cells; dashed line in Figure 2
top) and the assumption that dicentrics follow a Poisson dis-
tribution. Only three labs reported a number of aberrations
outside of this range (one for two slides and two for one
slide). This is noteworthy as 1–9 outliers are expected on
statistical grounds for the 92 dose estimates produced by the
laboratories. The estimated doses and 95% confidence inter-
vals for all slides (Figure 2, bottom) show a tendency for
overestimation of the physical dose (solid line). The mean
estimated dose for RENEB partners/RENEB candidates/and
non-EU partners in 50 cells was 1.18/0.98/1.07 Gy, respect-
ively. Two out of the nine networks reported an average
dose (not solid line) lower than the physical dose and seven
networks a higher dose; 65 (71%) out of 92 estimates fell
into the tolerance region (0.85 ± 0.5 Gy, shaded area) and
73 (79%) out of 92 confidence intervals (alpha 95%, vertical
lines) included the true physical dose.
The true physical dose was 2.7 Gy for the blood sample
RENEB 6 (Re6). In Figure 3 the results for the number of aber-
rations scored (top) and the doses estimations (bottom) are
shown. In total, the number of dicentrics analyzed in
50 cells/slide show a good agreement with the expected the-
oretical range (shaded area). Some 1–9 outliers are theoretic-
ally expected to lie outside of this range whereas both slides
for one dose-point are unlikely to fail without a systematic
factor. Eight of the participating labs were found outside the
range, four with one and four with two slides. Generally, the
estimated doses and 95% confidence intervals for all slides
show again a tendency for an overestimation of the physical
dose (solid line) by 12 labs. One laboratory (L8) reported an
underestimation with two slides outside of the tolerance
region.
A total of 55 (61%) out of 90 estimates fall into the toler-
ance region (2.7 Gy ±20%, shaded area) and 60 (67%) confi-
dence intervals (alpha 95%, vertical lines) include the
physical dose. One out of nine networks reported an average
dose (not solid line) lower than the physical dose, with all of
the others reporting a higher average dose.
Figure 4 shows the z-scores for all the estimated doses
based on 50 cells/slide (from left to right: Re5a, Re5b, Re6a,
Re6b). These were used to evaluate the performance of the
networks as a whole. Questionable results (2 < j z j < 3) for
at least one slide at one dose were reported by one RENEB
laboratory (L8). One lab of the RENEB partners (L6) shows
unsatisfactory high results (j z j  3) for the low dose point.
In general a tendency for overestimation of the doses (z > 0)
was observed. Some labs systematically reported an overesti-
mate of the dose but they are still satisfactory in all reported
values (L7, L9, L10, L11, L12).
For the RENEB candidates all results were in the satisfac-
tory range, even though, the number of scored cells were
very low by two laboratories, therefore showing larger 95%
confidence interval of the mean. For the non-EU partners,
Figure 1. Dose effect curves of the participating laboratories used for dose assessment based on dicentrics, dicentrics and rings or no information was given in the
scoring sheet. RENEB partner laboratories (L), RENEB candidates (C) and non-EU organizations (N).
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Figure 2. 2nd intercomparison – 0.85 Gy (Re 5) – top: Number of dicentrics in 50 cells scored for both slides of all participating laboratories, RENEB partners
(L1–L19), the RENEB candidates (C1–C4) and non-EU partners (N1–N23) (dots), the theoretical expectation range (shaded area) referring to the mean number of
dicentrics of all laboratories (5.13 dics/50cells; dashed line) and the assumption that dicentrics are Poisson distributed. bottom: Estimated doses and 95% confidence
intervals for all slides, physical dose (solid line), average dose (not solid line) and tolerance region (0.85 ± 0.5 Gy, shaded area).
Figure 3. 2nd intercomparison – 2.7 Gy (Re 6) – top: Number of dicentrics in 50 cells scored for both slides of all participating laboratories, RENEB partners
(L1–L19), the RENEB candidates (C1–C4) and non EU partners (N1–N23), (dots); the theoretical expectation range (shaded area) referring to the mean number of
dicentrics of all laboratories (28.8 dics/50 cells; dashed line) and the assumption that dicentrics are Poisson distributed. bottom: Estimated doses and 95% confi-
dence intervals for all slides, the physical dose (solid line), the mean dose (not solid line) and the tolerance region (2.7 Gy ±20%, shaded area).
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even the laboratories which received the blood samples with
a considerable delay (N10 and N12) obtained satisfactory
results, except for two laboratories (N8 (this laboratory par-
ticipated twice, N8 is also N14) and N9) as shown by the
questionable and unsatisfactory z-scores.
Classification of dose estimations
The classification of blood samples into medically relevant
doses is required to support the medical management of
patients in emergency situations. Therefore the percentage
of incorrectly classified samples was calculated for the two
dose-points used in the global exercise and for the different
number of scored cells (20, 30 and 50 cells) (Table 2). For the
low dose point, 0.85Gy, an incorrect classification of samples
was defined as 2Gy. For the high dose point the criteria
was 1Gy for a misclassification. In Table 2, the results show
that for the low dose point the percentage of incorrect classi-
fications was between 5.4 and 7.9%, scoring 50–20 cells,
respectively, for all participants. Clearly, increasing the num-
ber of scored cells from 20–50 had little effect on the mis-
classification of this dose. For the high dose-point (2.7 Gy)
there were no incorrect classifications for any group of labs
and different number of cells scored.
Discussion
The dicentric chromosome assay (DCA) is an important tool
in biological dosimetry to estimate an individual absorbed
dose to lymphocytes in peripheral blood (Voisin et al. 2004;
Romm et al. 2009; Wilkins et al. 2011). The standardization
and harmonization of the method is essential for the success-
ful networking of different laboratories in case of a large-
scale emergency situation. The potential and limits of the
Table 2. Classification of dose estimations performed in the frame of the 2nd intercomparison reported by the RENEB partners, RENEB candidates
and non-EU laboratories for low dose (0.85 Gy) and high dose (2.7 Gy) for 20, 30 and 50 cells scored.
0.85 Gy 1 Gy 12 Gy 2 Gy R 2.7 Gy 1 Gy 12 Gy 2 Gy R
N¼ 20 N¼ 20
RENEB Partner 13 22 2 37 RENEB Partner 0 1 37 38
RENEB Candidate 4 4 0 8 RENEB Candidate 0 1 7 8
non-EU 22 17 5 44 non-EU 0 1 44 45
R 39 43 7 89 R 0 3 88 91
% 43.8 48.3 7.9 % 0 3.3 96.7
N¼ 30 N¼ 30
RENEB Partner 11 25 2 38 RENEB Partner 0 2 36 38
RENEB Candidate 4 4 0 8 RENEB Candidate 0 0 8 8
non-EPU 22 16 5 43 Urn-EU 0 0 43 43
R 37 45 7 89 R 0 2 87 89
% 41.5 50.6 7.9 % 0 2.2 97.8
N¼ 50 N¼ 50
RENEB Partner 10 26 2 38 RENEB Partner 0 2 36 38
RENEB Candidate 4 4 0 8 RENEB Candidate 0 0 6 6
non-EU 24 19 3 46 non-EU 0 0 46 46
R 38 49 5 92 R 0 2 88 90
% 41.3 53.3 5.4 % 0 2.2 97.8
Figure 4. The z-scores for all estimated doses based on 50 cells/slide for all participating labs, RENEB partners (L1–L19), the RENEB candidates (C1–C4) and non-EU
partners (N1–N23). mean for the lab; 95% confidence interval of the mean; boundaries of classification.
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DCA have been evaluated in the frame of the RENEB project.
In contrast to similar activities done previously (Romm et al.
2011; Beinke et al. 2013; Jaworska et al. 2015) the number of
laboratories who joined the intercomparison was enhanced
and also organizations and established networks outside the
European community were included. In total 42 laboratories
from 31 countries participated in one of the two intercom-
parisons and 550 dose estimations for different number of
scored cells were recorded and included in the evaluation.
Furthermore, European biodosimetry laboratories had the
possibility to compare their results, generated within the
newly established RENEB network on an international level.
The general study design included shipment of blood
samples to the laboratories inside and outside of the
European community. The experiences gained from the ship-
ment procedure varied strongly depending on the place of
destination. The shipment to the partners within the EU was
performed successfully and within 24 h. Outside the
European community unacceptable delays were caused by
country-specific import regulations and shipments had to be
repeated using a specialized and expensive service for diag-
nostic materials. The results suggest that for large-scale acci-
dents, the shipment of blood samples to non-EU countries is
not advisable and can waste valuable time and money. An
option would be to include the high expertise of non-EU
countries for dose estimation by the use of web-based scor-
ing (see Romm et al. 2016). It is obvious that in a real acci-
dent situation time is limited and preplanning and exercising
for real events are necessary. This includes the preparation of
guidelines, information sheets and questionnaires in different
languages in advance and to have agreements in place with
delivery couriers.
The DCA is a well-established technique but there is not a
‘universal’ protocol used by all biodosimetry laboratories.
Despite considerable efforts for harmonization, culture condi-
tions show some range for variability, as reported by the par-
ticipants of the two RENEB intercomparisons. BrdU and
Colcemid concentration differed between laboratories as well
as the incubation time with Colcemid. However, in most
cases the range fell within the recommendations given in the
IAEA manual and ISO documentation. The majority of labora-
tories have used a cell cycle controlled scoring procedure to
avoid an underestimation of doses. Short-term (2–3 h)
Colcemid treatment using Fluorescence plus Giemsa (FpG)
staining and long-term (24 h) Colcemid treatment are the
techniques of choice. Most partners established their own
dose effect curves by closely following the IAEA recommen-
dation concerning the dose range (0–5.0 Gy) and the number
of dose-points (ideally up to 10). The slope of the curves dif-
fered between the partners according to the variations in lab
performance and scoring criteria. The use of each lab’s own
protocol, based on existing recommendations but established
for the particular laboratory, was shown to be appropriate to
achieve optimal results in the quality and quantity of meta-
phases. A crucial point is to apply the same procedure for
both, establishing the calibration curve and analyzing
chromosome aberrations in case of suspected overexposure.
The evaluation of the information sheets revealed that unsat-
isfactory results for dose estimation were achieved in the
intercomparisons when a laboratory did not have their own
dose effect curve available. The need for future exercises was
also obvious for laboratories scoring systematically too many
or too few aberrations and thus providing a dose estimation
outside the tolerance region.
In order to guarantee high quality performance within the
RENEB network, a long-term training program was designed
to maintain reliability of the dose estimate for each assay
and for each partner laboratory (Gregoire et al. 2016). Here
clear criteria for ‘RENEB approbation’ are established. If a
given laboratory does not meet several criteria, it is proposed
to perform:
 Training according to the identified needs. The training
can include practical courses including trouble shooting,
seminars on QA, statistics, dosimetry, online training (e.g.
picture analysis), or other upcoming topics.
 The training has to be organized by a qualified
laboratory.
 Take part in new intercomparisons.
 It is also possible to participate in biological dosimetry
courses organized by the agencies (IAEA, WHO, IABEARD).
The DCA is highly radiation sensitive, with a threshold for
whole-body dose of 0.1–0.2 Gy based on analysis of 1000
metaphase spreads (Wilkins et al. 2008). The number of cells
analyzed influences the statistical accuracy of the dose esti-
mation. The most reliable results were obtained for individual
dose estimates based on analyzing between 500 and 1000
cells. One important strategy for increasing the capacity of
the assay in the case of a large accident situation is to
increase the number of analyzed persons by reducing the
number of analyzed cells to 20 or 50 cells or 30 dicentrics
(Lloyd et al. 2000). This procedure leads to a larger uncer-
tainty interval, but in the case of a mass casualty scenario, a
rapid categorization of potentially overexposed victims into
clinically relevant treatment groups is of prime importance
(Beinke et al. 2013; De Amicis et al. 2014). Preliminary individ-
ual dose categorization based on a smaller number of cells,
is therefore considered as the initial dosimetric information
for clinicians to assist the patient management and to iden-
tify the ‘worried well’ persons. It is especially important to
identify the latter group, comprising people that show radi-
ation sympthoms due to mental stress or pre-existing infec-
tion but without having received a corresponding dose, as
they could overwhelm medical centers (Kulka et al. 2016). In
addition, the more accurate, but time-consuming, chromo-
some dosimetry based on a higer number cells could then
be targeted more effectively if required at a later date.
The results produced in the frame of the RENEB project
demonstrate very clearly that the classification of the blood
samples into medically relevant dose categories was
performed very successfully (Table 2) for lower and higher
dose-points by the majority of blood samples analyzed.
Therefore the DCA as a part of the operational basis in the
RENEB network (Wojcik et al. 2016) has to be considered as
an important tool to assist in the medical management of
radiation injuries. In comparison to the 1st exercise, which
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also included one low (0.94 Gy) and one high (3.27 Gy) dose,
the percentage of correct dose estimations in the 2nd exer-
cise was increased from 39–61% for the high dose-point for
the RENEB partners. For the low dose-point, the percentage
of correct dose estimations did not change (81–76%).
Regularly performed intercomparisons are necessary to iden-
tify, improve and maintain the quality of dose estimations
from the network.
The relative amount of correctly classified dose estima-
tions did not improve for an acute whole body irradiation,
when the number of scored cells was increased from 30–50,
for both the low and high dose samples. This confirms
results, achieved in previous exercises (MULTIBIODOSE,
NATO) that the use of a number of cells as low as 30 or even
20 can give a rough indication of a whole body dose.
However it must be kept in mind that larger numbers of cells
are appropriate in the case of a partial body irradiation
(Lloyd et al. 2000). As shown in the MULTIBIODOSE project in
order to identify a 50% partial body exposures at 2 Gy with
an accuracy of ±0.5 Gy approximately 150 cells would have
to be scored (Romm et al. 2016).
The joint lab performance in this exercise based on the
z-test demonstrates a low number of unsatisfactory results.
Overall, a tendency for overestimation of the doses (z> 0)
was observed, however the results were still satisfactory in all
reported z-values. Investigations performed in the QA/QM
program of RENEB evaluated the influence of different cali-
bration conditions on the results of dose estimations within
the RENEB partners. Inherent variability on delivered dose
from one radiation facility to another can be responsible for
systematic bias. More details about this issue are discussed
by Trompier et al. (2016) in this special issue.
Conclusions
The two intercomparisons performed in the frame of the
RENEB project show very encouraging results for the DCA
and validate the assay as an established biodosimetric tool
for networks in large-scale radiation scenarios. The pooling of
biodosimetry laboratory resources within a network enables
a rapid and reliable categorisation of affected persons in
medical relevant treatment groups in case of an emergency
situation. As a consequence, the network can assist in the
clinical and diagnostic needs in emergency situations and
contribute to the reassurance of the public by identification
of the ‘worried well’ persons.
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